Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Experts urge early detection & better access to care
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
ANVIMO will be available in dosages of 240 mg and 480 mg
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
This collaboration aims to bridge modern scientific research with traditional Ayurvedic wisdom, fostering innovative solutions that support holistic well-being
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Subscribe To Our Newsletter & Stay Updated